|
Back to:
Tazofelone
(Last updated March 2026)
Figure 1. The molecular diagram of Tazofelone.
CSP studies
| REFCODE | |
| Formula | C18 H27 N1 O2 S1 |
| Common Name | Tazofelone |
| IUPAC Systematic Name | 2,6-di-tert-butyl-4-(1,3-thiazolidin-5-ylmethyl)phenol |
| Other Names | |
| CSD Refcodes | WILZUM, WIMBAV08, WIMBAV10, WIMBAV12, WIMBAV07 |
| |
| Search Identifier | |
| Scientist | Louise Price |
| Date | 2013 |
| Publication | Price LS, McMahon JA, Lingireddy SR, Lau S-F, Diseroad BA, Price SL, Reutzel-Edens SM 2014. J Mol Struct. 1078, 26-42. |
| Energy model | |
| Study_ID | 10 |
| Programs | Study_ID=20, CrystalOptimizer, DMACRYS (2.0.8beta4) |
| Location on S Drive | \CHEMISTRY_CPOSS\Tazofelone\Tazofelone_CO |
| Potential Description | CrystalOptimizer with PBE0/6-31G(d,p) Intra and GDMA2.2(PBE0/6-31G(d,p)) + FIT with isotropic S |
| Intramolecular Description | PBE0/6-31G(d,p) |
| Energy model | |
| Study_ID | 20 |
| Programs | Flexible CrystalPredictor (2), DMACRYS (2.0.8beta4) |
| Location on S Drive | \CHEMISTRY_CPOSS\Tazofelone\Tazofelone_CP |
| Potential Description | CrystalPredictor, single point DMACRYS with GDMA2.2(PBE0/6-31G(d,p)) + FIT |
| Intramolecular Description | PBE0/6-31G(d,p) |
Figure 2. Lattice Energy Landscape of Tazofelone. Energy model A2.
CSD structures (CSD version 6.01 with Feb 2026 update)
Table 1. Crystallographic information and experimental information of CSD entries for Tazofelone. Different polymorphs, as ascertained by structure matching of 20 molecule coordination sphere in Mercury, are coloured differently. Reference polymorphs are outlined in bold.
| REFCODE | Spacegroup | Z' | a / Å | b / Å | c / Å | α / ° | β / ° | γ / ° | density / g cm-3 | Form | R factor | T / K | Year | Comment / reference | REFCODE |
| WILZUM | P21 | 2.0 | 9.392 | 10.962 | 17.823 | 90.0 | 94.29 | 90.0 | 1.1669 | None | 5.54 | at 293 K | 2000 | 10.1039/a909259e | WILZUM |
| WIMBAV | Pbca | 1.0 | 17.204 | 11.287 | 18.86 | 90.0 | 90.0 | 90.0 | 1.1661 | polymorph I | 4.94 | None | 2000 | 10.1039/a909259e | WIMBAV |
| WIMBAV01 | P21/c | 2.0 | 11.313 | 17.082 | 19.324 | 90.0 | 101.11 | 90.0 | 1.1654 | polymorph II | 6.36 | at 293 K | 2000 | 10.1039/a909259e | WIMBAV01 |
| WIMBAV06 | P21/n | 1.0 | 9.38820 | 10.9503 | 17.855 | 90.0 | 93.766 | 90.0 | 1.1658 | polymorph III | 12.08 | at 296 K | 2006 | 10.1021/ja063450l | WIMBAV06 |
| WIMBAV07 | P21/n | 1.0 | 9.21060 | 10.9363 | 17.6476 | 90.0 | 93.331 | 90.0 | 1.2032 | polymorph III | 6.310 | at 100 K | 2006 | 10.1021/ja063450l | WIMBAV07 |
| WIMBAV08 | P21/c | 2.0 | 11.0992 | 16.9748 | 19.2201 | 90.0 | 100.5695 | 90.0 | 1.1996 | metastable RCI polymorph | 5.47 | 100 K | 2014 | 10.1016/j.molstruc.2014.01.014 | WIMBAV08 |
| WIMBAV09 | P21/c | 2.0 | 11.3103 | 17.0578 | 19.3296 | 90.0 | 101.029 | 90.0 | 1.1667 | metastable RCI polymorph | 7.12 | 296 K | 2014 | 10.1016/j.molstruc.2014.01.014 | WIMBAV09 |
| WIMBAV10 | Pbca | 1.0 | 17.1102 | 11.0958 | 18.6504 | 90.0 | 90.0 | 90.0 | 1.2061 | RCII polymorph | 4.52 | 100 K | 2014 | 10.1016/j.molstruc.2014.01.014 | WIMBAV10 |
| WIMBAV11 | Pbca | 1.0 | 17.1967 | 11.2756 | 18.8057 | 90.0 | 90.0 | 90.0 | 1.1711 | RCII polymorph | 5.52 | 296 K | 2014 | 10.1016/j.molstruc.2014.01.014 | WIMBAV11 |
| WIMBAV12 | P-1 | 2.0 | 11.105 | 11.8502 | 14.9408 | 77.672 | 75.185 | 71.44 | 1.1975 | metastable RCIII polymorph | 7.71 | 100 K | 2014 | 10.1016/j.molstruc.2014.01.014 | WIMBAV12 |
| WIMBAV13 | P-1 | 2.0 | 11.2917 | 11.9167 | 14.9597 | 77.827 | 75.208 | 71.585000 | 1.1681 | metastable RCIII polymorph | 8.74 | 115 K | 2014 | 10.1016/j.molstruc.2014.01.014 | WIMBAV13 |
The names of forms in Table 1 are misleading. The original patent had a mixture of forms at “Form 1” and Form 2 was the only neat polymorph. Hence WIMBAV and WIMBAV01 are misnamed. WIMBAV06 and WIMBAV07 are actually a solid solution of the R and S enantiomers. WIMBAC08-13 are from our paper, so I want to go with that naming. The colors are from a Crystal Packing Similarity search in Mercury, so are valid.
|